ASP Isotopes Inc.
Nasdaq · CIK 0001921865 · Fiscal year end 1231
Latest reported period: Latest published period
Revenue
$4.2M
Cost Of Revenue
$2.5M
Gross Profit
$1.7M
Recent financials
| Metric | Current | Prior | Change |
|---|---|---|---|
| Revenue | $4.2M | - | - |
| Cost Of Revenue | $2.5M | - | - |
| Gross Profit | $1.7M | - | - |
| Operating Income | $-24.9M | - | - |
| Net Income | $-7.1M | - | - |
| Eps Basic | -0.06 | - | - |
| Eps Diluted | -0.06 | - | - |
| Cash And Equivalents | $207.3M | - | - |
| Total Assets | $587.7M | - | - |
| Total Liabilities | $288.7M | - | - |
| Shareholders Equity | $289.0M | - | - |
| Operating Cash Flow | $-17.8M | - | - |
| Capital Expenditures | $6.1M | - | - |
Latest filings
| Form | Company | Filed | Accession |
|---|---|---|---|
| 10-Q | ASP Isotopes Inc. | 2026-05-20 | 0001193125-26-232658 |
| 10-K | ASP Isotopes Inc. | 2026-04-10 | 0001193125-26-151294 |
| 10-Q | ASP Isotopes Inc. | 2025-11-19 | 0001193125-25-288168 |
| 10-Q | ASP Isotopes Inc. | 2025-08-14 | 0000950170-25-108971 |